| CBRE |
Report |
Adjusted EPS - Diluted |
BEAT |
pred ~$1.62 vs. cons $1.479 (+9.5%) |
HIGH |
| CBRE |
Report |
Leasing Revenue |
BEAT |
pred ~$1,195M vs. cons $1,145M (+4.4%) |
MEDIUM |
| CBRE |
Report |
Advisory Sales (Property Sales) |
BEAT |
pred ~$580M vs. cons $542M (+7.0%) |
MEDIUM |
| CBRE |
Guide |
Core EPS (FY2026) |
BETTER |
guide ~$7.85-$8.05 mid vs. cons $7.718 (+3.0%) |
MEDIUM |
| CBRE |
Guide |
Advisory SOP Growth (FY2026) |
UNCHANGED |
reiterate high-teens vs. cons implied |
HIGH |
| CBRE |
Guide |
BOE SOP Growth (FY2026) |
UNCHANGED |
reiterate ~25% vs. cons implied |
HIGH |
| CBRE |
Return |
Day-1 residual (stock − beta × S&P 500) |
+4.5% |
— |
MEDIUM |
| CBRE |
Return |
5-day cumulative residual |
+6.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — H2 estimate revisions drive continued upside as Street models the implied H2 raise |
MEDIUM |